EWP
ABVX

Elevation Wealth Partners’s Abivax ABVX Stock Holding History

Elevation Wealth Partners’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6K Buy
+27
New +$3.06K ﹤0.01% 1094

Other funds holding ABVX

NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
SCS
Syquant Capital SAS Paris, France $447M AUM 13.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM

Elevation Wealth Partners's ABVX Position: Q2 2026 in Review

Elevation Wealth Partners opened a new position in Abivax (ABVX) in Q2 2026: 27 shares worth $3.6K. The stake represents ﹤0.01% of the portfolio and ranks #1094 among its holdings.

52 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Elevation Wealth Partners held 27 shares of Abivax worth $3.6K as of Q2 2026.
  • Abivax was a new Elevation Wealth Partners position in Q2 2026.
  • Abivax made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #1094 holding.
  • 52 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.